Quality of life of lung cancer patients receiving outpatient chemotherapy

被引:7
作者
Matsuda, Ayako [1 ]
Kobayashi, Mika
Sakakibara, Yumi [2 ]
Tamaoka, Meiyo [2 ]
Furuiye, Masashi [2 ]
Inase, Naohiko [2 ]
Matsushima, Eisuke
机构
[1] Tokyo Med & Dent Univ, Dept Liaison Psychiat & Palliat Med, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo 1138519, Japan
[2] Tokyo Med & Dent Univ, Dept Integrated Pulmonol, Grad Sch Med & Dent Sci, Tokyo 1138519, Japan
关键词
chemotherapy; lung cancer; outpatient; quality of life; DEPRESSION; PREVALENCE; DISTRESS; ANXIETY;
D O I
10.3892/etm.2011.185
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
An increasing number of cancer patients receive outpatient chemotherapy as an alternative to inpatient chemotherapy. The aim of this study was to investigate whether quality of life (QOL) during outpatient chemotherapy was better than QOL prior to hospital discharge, and to explore possible related factors prior to hospital discharge that affected the QOL of lung cancer patients who received outpatient chemotherapy. Lung cancer inpatients who were scheduled for outpatient chemotherapy were assessed two times (prior to hospital discharge and during outpatient chemotherapy) using the Functional Assessment of Cancer Therapy-Lung and Hospital Anxiety and Depression Scale. A total of 40 patients completed all assessments, both prior to hospital discharge and during outpatient chemotherapy. In the present study, QOL during outpatient chemotherapy was not significantly different when compared with the QOL prior to hospital discharge, and predictors prior to hospital discharge for a better QOL of patients during outpatient chemotherapy included better social, emotional and physical well-being. These results suggest that medical staff, in particular those involved in outpatient chemotherapy, need to recognize social and emotional as well as physical well-being prior to hospital discharge, regardless of cancer-related factors and the personal characteristics of the patients.
引用
收藏
页码:291 / 294
页数:4
相关论文
共 23 条
[1]  
AGRA Y, 2009, COCHRANE DB SYST REV, V7
[2]  
[Anonymous], 1996, J Clin Oncol, V14, P671
[3]   RELIABILITY AND VALIDITY OF THE FUNCTIONAL ASSESSMENT OF CANCER-THERAPY - LUNG (FACT-L) QUALITY-OF-LIFE INSTRUMENT [J].
CELLA, DF ;
BONOMI, AE ;
LLOYD, SR ;
TULSKY, DS ;
KAPLAN, E ;
BONOMI, P .
LUNG CANCER, 1995, 12 (03) :199-220
[4]  
Clark R, 1998, ONCOLOGY-NY, V12, P647
[5]  
*CTR CANC CONTR IN, DAT SOURC VIT STAT J
[6]   Treatment of advanced non-small cell lung cancer [J].
De Petris, L ;
Crinò, L ;
Scagliotti, GV ;
Gridelli, C ;
Galetta, D ;
Metro, G ;
Novello, S ;
Maione, P ;
Colucci, G ;
de Marinis, F .
ANNALS OF ONCOLOGY, 2006, 17 :36-41
[7]   THE PREVALENCE OF PSYCHIATRIC-DISORDERS AMONG CANCER-PATIENTS [J].
DEROGATIS, LR ;
MORROW, GR ;
FETTING, J ;
PENMAN, D ;
PIASETSKY, S ;
SCHMALE, AM ;
HENRICHS, M ;
CARNICKE, CLM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 249 (06) :751-757
[8]  
Ettinger David S, 2008, J Natl Compr Canc Netw, V6, P228
[9]   The role of palliative care in the lung cancer patient: can we improve quality while limiting futile care? [J].
Freedman, Orit C. ;
Zimmermann, Camilla .
CURRENT OPINION IN PULMONARY MEDICINE, 2009, 15 (04) :321-326
[10]   Quality-of-life assessment in advanced lung cancer: considerations for evaluation in patients receiving chemotherapy [J].
Gralla, RJ ;
Thatcher, N .
LUNG CANCER, 2004, 46 :S41-S47